Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996

American Journal of Public Health

Volumn 88, Issue 12, 1998, Pages 1801-1806

  Des Jarlais, Don C ^a,b   Perlis, Theresa ^b   Friedman, Samuel R ^b   Deren, Sherry ^b   Chapman, Timothy ^b   Sotheran, Jo L ^b   Tortu, Stephanie ^b   Beardsley, Mark ^b   Paone, Denise ^a   Torian, Lucia V ^c   Beatrice, Sara T ^c   DeBernardo, Erica ^c   Monterroso, Edgar ^d   Marmor, Michael ^e  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c New York City Department of Health

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; EPIDEMIC; FEMALE; HEALTH CARE FACILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

EID: 0032445510     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.88.12.1801     Document Type: Article

References (10)

1. AIDS Surveillance Update. New York: New York City Department of Health, Office of AIDS Surveillance; 1997.
2. European Centre for the Epidemiological Monitoring of AIDS. Third Quarterly Report. Paris: 1997.
3. Report of the Expert Panel on HIV Seroprevalence Estimates and AIDS Case Projection Methodologies. New York: New York City Department of Health; 1989.
4. Eisenhandler J, Drucker E. Opiate dependency among the subscribers of a New York area private insurance plan. JAMA. 1993;269:2890-2891.
5. Frank B, Galea J. Recent trends in drug use in New York City. In: Kozell N, ed. Community Epidemiology Working Group Report. Rockville, Md: National Institute on Drug Abuse. In press.
6. Des Jarlais DC, Friedman SR, Novick D, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989;261:1008-1012.
7. Des Jarlais DC, Friedman SR, Sotheran JL, et al. Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992. JAMA. 1994;271:121-127.
8. Holmberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642-654.
9. Caussy D, Weiss S, Blattner W, et al. Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs. AIDS Res Hum Retroviruses. 1990;6:1459-1467.
10. D'Aquila RT, Williams AB, Petersen LR, Williams AE. HIV seroprevalence among Connecticut intravenous drug users in 1986-87: race/ethnicity as a risk factor for HIV seropositivity. Paper presented at: Third International Conference on AIDS; June 1-5,1987; Washington, DC.